Clinical Trials

A011801: The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04457596
Englewood Health IRB #: E-21-850
More Information (clinicaltrials.gov)

COMET: Comparison Of Operative To Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS: A Phase III Prospective Randomized Trial

Principal Investigator: Steven Brower, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02926911
Englewood Health IRB #: E-17-710
More Information (clinicaltrials.gov)